Zobrazeno 1 - 5
of 5
pro vyhledávání: '"V. B Saparova"'
Publikováno v:
Ведомости Научного центра экспертизы средств медицинского применения, Vol 13, Iss 1, Pp 77-88 (2023)
Russian and international regulatory documents require that analytical procedures for establishing bioequivalence and comparability of quality attributes of biotechnological (biological) products, carrying out batch release of medicinal products, and
Externí odkaz:
https://doaj.org/article/d6fd7359d73b4bbc8d3817c970259007
Autor:
A. N. Afanasyeva, V. B. Saparova, D. D. Karal-Ogly, E. I. Mukhametzyanova, D. V. Kurkin, A. V. Kalatanova, I. E. Makarenko, A. L. Khokhlov, I. A. Lugovik
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 4, Pp 354-370 (2022)
Idiopathic thrombocytopenic purpura is a chronic autoimmune hematological disease caused by an increased destruction of platelets and associated thrombocytopenia, for the treatment of which the imported drug romiplostim is used. Сreation of the drug
Externí odkaz:
https://doaj.org/article/a5cc49ccab96497c88981a4904fcda8c
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai, V. I. Petrov
Publikováno v:
Pharmacy & Pharmacology. 11:19-47
Modern requirements for the treatment of type 2 diabetes mellitus (DM2) include not only achieving a glycemic control, but also reducing the risk of developing cardiovascular complications. Dipeptidyl peptidase 4 (DPP-4) inhibitors are inferior in th
Autor:
D. V Kurkin, E. I Morkovin, D. A Bakulin, Yu. V Gorbunova, A. V Strygin, A. I Robertus, I. E Makarenko, V. B Saparova, R. V Drai, V. I Petrov
Publikováno v:
Journal of Volgograd State Medical University. 19:34-49
Resume. In Russia, type 2 diabetes affects more than 5 % of the population. Type 2 diabetes accounts for up to 95 % of all cases of diabetes meUitus, but its pathogenetic mechanisms have not yet been fully established. Aim. To summarize and analyze t
Autor:
Elena V. Chernigovskaya, D. V. Zosen, A. S. Berezovskaya, E. V. Nasluzova, E. L. Gorbacheva, V. B. Saparova, Margarita Glazova, V. T. Bakhteeva
Publikováno v:
Neuroscience and Behavioral Physiology. 49:765-772
Epilepsy is known to be associated with impairment to neurogenesis processes. Studies have identified a number of genes whose mutations are liked with the development of inherited forms of epilepsy, and some of these genes are involved in controlling